FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.4  |  FHIR Version n/a  User: [n/a]

421203005: Tenofovir disoproxil (substance)


Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 01-Jul 2024. Module: IPS terminology module (core metadata concept)

Descriptions:

Id Description Lang Type Status Case? Module
2614923016 Tenofovir disoproxil (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) IPS terminology module (core metadata concept)
2617553010 Tenofovir disoproxil en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) IPS terminology module (core metadata concept)


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Tenofovir disoproxil (substance) Is a Anti-infective agent (substance) true Inferred relationship Some
Tenofovir disoproxil (substance) Is a Ester (substance) true Inferred relationship Some
Tenofovir disoproxil (substance) Is a Substance categorized by disposition true Inferred relationship Some
Tenofovir disoproxil (substance) Is a Carboxylic acid and/or carboxylic acid derivative (substance) true Inferred relationship Some
Tenofovir disoproxil (substance) Has disposition (attribute) Disposition true Inferred relationship Some

Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing precisely dolutegravir (as dolutegravir sodium) 50 milligram and lamivudine 300 milligram and tenofovir disoproxil (as tenofovir disoproxil fumarate) 245 milligram/1 each conventional release oral tablet (clinical drug) Has basis of strength substance (attribute) True Tenofovir disoproxil (substance) Inferred relationship Some 2
Product containing precisely tenofovir disoproxil (as tenofovir disoproxil fumarate) 245 milligram/1 each conventional release oral tablet (clinical drug) Has basis of strength substance (attribute) True Tenofovir disoproxil (substance) Inferred relationship Some 1
Product containing precisely efavirenz 400 milligram and lamivudine 300 milligram and tenofovir disoproxil (as tenofovir disoproxil fumarate) 245 milligram/1 each conventional release oral tablet (clinical drug) Has basis of strength substance (attribute) True Tenofovir disoproxil (substance) Inferred relationship Some 3
Emtricitabine 200 mg and tenofovir disoproxil (as tenofovir disoproxil fumarate) 245 mg oral tablet Has basis of strength substance (attribute) True Tenofovir disoproxil (substance) Inferred relationship Some 2

This concept is not in any reference sets

Back to Start